Feng Gao, Yimin Chen, Mingjian Bei, Yixiao Chen, Ruijiang Li, Shanbin Xu, Liunan Chen, Zhelun Tan, Gang Liu, Minghui Yang, Xinbao Wu
Lower preoperative mFES scores were independently associated with increased postoperative mortality in older adults undergoing hip fracture surgery. The association was strongest for 30-day mortality, while a weaker but persistent association with long-term mortality was also observed over the 3-year follow-up period.
PURPOSE: To examine whether preoperative fear of falling, measured with the modified Falls Efficacy Scale (mFES), is associated with short-term (30-day) and long-term (3-year) postoperative mortality in older adults undergoing hip fracture surgery.
METHODS: This post-hoc analysis was based on a prospective observational cohort study. Patients aged ≥ 65 years who underwent surgery for hip fractures between November 2018 and November 2019 were included. Fear of falling was assessed at admission using the mFES. All-cause mortality was assessed by telephone follow-up at 30-day, 120-day, 1-year, and 3-year after admission. Logistic regression and Cox proportional hazards models were used to evaluate the associations between mFES score and short-term and long-term mortality.
RESULTS: A total of 1092 patients were enrolled. The median mFES score was 8.04 (IQR 5.75-10.00). In the multivariable logistic regression analysis, higher mFES scores were independently associated with lower odds of 30-day mortality (adjusted OR 0.780, 95% CI 0.625-0.974, P = 0.028). In the multivariable Cox proportional hazards model, higher mFES scores also remained independently associated with lower long-term mortality risk during the 3-year follow-up period (adjusted HR 0.925, 95% CI 0.874-0.979, P = 0.007).
CONCLUSION: Lower preoperative mFES scores were independently associated with increased postoperative mortality in older adults undergoing hip fracture surgery. The association was strongest for 30-day mortality, while a weaker but persistent association with long-term mortality was also observed over the 3-year follow-up period.